| Product Code: ETC13372938 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Shrimp Disease Diagnostics Market was valued at USD 0.46 Billion in 2024 and is expected to reach USD 0.69 Billion by 2031, growing at a compound annual growth rate of 5.90% during the forecast period (2025-2031).
The Global Shrimp Disease Diagnostics Market is experiencing significant growth driven by the rising demand for shrimp products worldwide. The market is characterized by the increasing prevalence of various diseases affecting shrimp farming, leading to the need for accurate diagnostics solutions. Key factors such as the expansion of shrimp aquaculture, rising awareness among farmers about disease prevention, and advancements in diagnostic technologies are fueling market growth. Companies in the market are focusing on developing innovative diagnostic tools to enhance disease detection accuracy and efficiency. Geographically, Asia Pacific dominates the market due to its prominent shrimp farming industry. However, North America and Europe are also witnessing growth due to the increasing consumption of shrimp products in these regions. Overall, the Global Shrimp Disease Diagnostics Market is projected to continue its expansion in the coming years.
The Global Shrimp Disease Diagnostics Market is witnessing a growing demand for advanced diagnostic tools to detect and manage various diseases affecting shrimp farming. Key trends include the adoption of molecular diagnostic techniques for precise and rapid detection, the integration of artificial intelligence and big data analytics for disease prediction and management, and the development of point-of-care testing devices for on-site diagnosis. Opportunities in the market lie in expanding research and development activities to introduce innovative diagnostic solutions, collaborating with aquaculture industry players to address disease outbreaks effectively, and focusing on emerging markets with a high potential for shrimp farming. Overall, the market is poised for significant growth driven by increasing awareness about disease prevention in shrimp aquaculture and the rising global demand for shrimp products.
The Global Shrimp Disease Diagnostics Market faces several challenges, including the lack of standardized diagnostic techniques across regions leading to inconsistent results and misdiagnosis. Additionally, the high cost associated with advanced diagnostic technologies can hinder market growth, especially for small-scale shrimp farmers. Limited awareness about the importance of disease diagnostics in shrimp farming and the lack of skilled personnel to perform accurate diagnostics are also significant challenges. Furthermore, the emergence of new and complex shrimp diseases that require specialized diagnostic tools adds further complexity to the market. Overcoming these challenges will require investment in research and development for affordable and user-friendly diagnostic solutions, along with increased education and training for shrimp farmers and industry professionals.
The Global Shrimp Disease Diagnostics Market is primarily driven by the increasing prevalence of shrimp diseases such as White Spot Syndrome Virus (WSSV) and Taura Syndrome Virus (TSV), leading to significant economic losses in the aquaculture industry. Additionally, the growing demand for shrimp products worldwide has heightened the need for efficient disease diagnostics to ensure the health and quality of shrimp stocks. Technological advancements in diagnostic tools, such as PCR and ELISA kits, have also propelled market growth by enabling rapid and accurate detection of shrimp diseases. Furthermore, stringent regulations regarding food safety and increasing investments in aquaculture research and development are further fueling the demand for advanced disease diagnostics in the shrimp farming sector.
Government policies related to the Global Shrimp Disease Diagnostics Market primarily focus on ensuring the health and sustainability of shrimp farming practices. Regulations often require mandatory testing for diseases such as white spot syndrome virus and infectious hypodermal and hematopoietic necrosis virus to prevent outbreaks and protect the industry. Government agencies may also provide guidelines and support for the development and adoption of advanced diagnostic technologies to enhance disease surveillance and control measures. Additionally, policies may address environmental concerns related to shrimp farming, emphasizing sustainable practices to minimize the impact on ecosystems. Overall, government policies aim to promote the growth of the Global Shrimp Disease Diagnostics Market while safeguarding the health of shrimp populations and the environment.
The Global Shrimp Disease Diagnostics Market is expected to witness steady growth in the coming years due to the increasing demand for shrimp products worldwide. The rise in aquaculture production, coupled with the growing prevalence of diseases affecting shrimp populations, will drive the need for efficient and accurate diagnostic tools. Technological advancements in disease detection methods, such as PCR-based assays and rapid testing kits, will further fuel market growth. Additionally, stringent regulations and quality standards in the aquaculture industry will drive the adoption of advanced diagnostics to ensure the health and safety of shrimp populations. Overall, the Global Shrimp Disease Diagnostics Market is poised for expansion as the aquaculture sector continues to expand and focus on sustainable practices.
In the Global Shrimp Disease Diagnostics Market, Asia holds a significant share due to the large shrimp farming industry in countries like China, India, and Indonesia. North America and Europe are also key regions with advanced diagnostic technologies and stringent regulations ensuring high standards of shrimp health. In the Middle East and Africa, the market is growing steadily as aquaculture gains traction in countries like Egypt and South Africa. Latin America is witnessing rapid growth in shrimp farming, particularly in countries such as Ecuador and Brazil, driving the demand for efficient disease diagnostics. Overall, the market is characterized by increasing awareness about the economic importance of early disease detection in shrimp farming across all regions.
Global Shrimp Disease Diagnostics Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Shrimp Disease Diagnostics Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Shrimp Disease Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 Global Shrimp Disease Diagnostics Market - Industry Life Cycle |
3.4 Global Shrimp Disease Diagnostics Market - Porter's Five Forces |
3.5 Global Shrimp Disease Diagnostics Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Shrimp Disease Diagnostics Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Global Shrimp Disease Diagnostics Market Revenues & Volume Share, By Testing Method, 2021 & 2031F |
3.8 Global Shrimp Disease Diagnostics Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 Global Shrimp Disease Diagnostics Market Revenues & Volume Share, By End Use, 2021 & 2031F |
4 Global Shrimp Disease Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Shrimp Disease Diagnostics Market Trends |
6 Global Shrimp Disease Diagnostics Market, 2021 - 2031 |
6.1 Global Shrimp Disease Diagnostics Market, Revenues & Volume, By Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Shrimp Disease Diagnostics Market, Revenues & Volume, By Viral Disease Detection, 2021 - 2031 |
6.1.3 Global Shrimp Disease Diagnostics Market, Revenues & Volume, By Bacterial Infection Test, 2021 - 2031 |
6.1.4 Global Shrimp Disease Diagnostics Market, Revenues & Volume, By Fungal Infection Test, 2021 - 2031 |
6.1.5 Global Shrimp Disease Diagnostics Market, Revenues & Volume, By Parasitic Disease Test, 2021 - 2031 |
6.1.6 Global Shrimp Disease Diagnostics Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 Global Shrimp Disease Diagnostics Market, Revenues & Volume, By Testing Method, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Shrimp Disease Diagnostics Market, Revenues & Volume, By PCR, 2021 - 2031 |
6.2.3 Global Shrimp Disease Diagnostics Market, Revenues & Volume, By ELISA, 2021 - 2031 |
6.2.4 Global Shrimp Disease Diagnostics Market, Revenues & Volume, By Microscopy, 2021 - 2031 |
6.2.5 Global Shrimp Disease Diagnostics Market, Revenues & Volume, By Rapid Kits, 2021 - 2031 |
6.3 Global Shrimp Disease Diagnostics Market, Revenues & Volume, By Application, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Shrimp Disease Diagnostics Market, Revenues & Volume, By Disease Monitoring, 2021 - 2031 |
6.3.3 Global Shrimp Disease Diagnostics Market, Revenues & Volume, By Routine Testing, 2021 - 2031 |
6.3.4 Global Shrimp Disease Diagnostics Market, Revenues & Volume, By Water Quality Control, 2021 - 2031 |
6.3.5 Global Shrimp Disease Diagnostics Market, Revenues & Volume, By On-site Diagnosis, 2021 - 2031 |
6.3.6 Global Shrimp Disease Diagnostics Market, Revenues & Volume, By Laboratory Testing, 2021 - 2031 |
6.4 Global Shrimp Disease Diagnostics Market, Revenues & Volume, By End Use, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Shrimp Disease Diagnostics Market, Revenues & Volume, By Aquaculture, 2021 - 2031 |
6.4.3 Global Shrimp Disease Diagnostics Market, Revenues & Volume, By Research Institutes, 2021 - 2031 |
6.4.4 Global Shrimp Disease Diagnostics Market, Revenues & Volume, By Hatcheries, 2021 - 2031 |
6.4.5 Global Shrimp Disease Diagnostics Market, Revenues & Volume, By Government Agencies, 2021 - 2031 |
6.4.6 Global Shrimp Disease Diagnostics Market, Revenues & Volume, By Fisheries, 2021 - 2031 |
7 North America Shrimp Disease Diagnostics Market, Overview & Analysis |
7.1 North America Shrimp Disease Diagnostics Market Revenues & Volume, 2021 - 2031 |
7.2 North America Shrimp Disease Diagnostics Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Shrimp Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Shrimp Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Shrimp Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Shrimp Disease Diagnostics Market, Revenues & Volume, By Type, 2021 - 2031 |
7.4 North America Shrimp Disease Diagnostics Market, Revenues & Volume, By Testing Method, 2021 - 2031 |
7.5 North America Shrimp Disease Diagnostics Market, Revenues & Volume, By Application, 2021 - 2031 |
7.6 North America Shrimp Disease Diagnostics Market, Revenues & Volume, By End Use, 2021 - 2031 |
8 Latin America (LATAM) Shrimp Disease Diagnostics Market, Overview & Analysis |
8.1 Latin America (LATAM) Shrimp Disease Diagnostics Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Shrimp Disease Diagnostics Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Shrimp Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Shrimp Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Shrimp Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Shrimp Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Shrimp Disease Diagnostics Market, Revenues & Volume, By Type, 2021 - 2031 |
8.4 Latin America (LATAM) Shrimp Disease Diagnostics Market, Revenues & Volume, By Testing Method, 2021 - 2031 |
8.5 Latin America (LATAM) Shrimp Disease Diagnostics Market, Revenues & Volume, By Application, 2021 - 2031 |
8.6 Latin America (LATAM) Shrimp Disease Diagnostics Market, Revenues & Volume, By End Use, 2021 - 2031 |
9 Asia Shrimp Disease Diagnostics Market, Overview & Analysis |
9.1 Asia Shrimp Disease Diagnostics Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Shrimp Disease Diagnostics Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Shrimp Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Shrimp Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Shrimp Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Shrimp Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Shrimp Disease Diagnostics Market, Revenues & Volume, By Type, 2021 - 2031 |
9.4 Asia Shrimp Disease Diagnostics Market, Revenues & Volume, By Testing Method, 2021 - 2031 |
9.5 Asia Shrimp Disease Diagnostics Market, Revenues & Volume, By Application, 2021 - 2031 |
9.6 Asia Shrimp Disease Diagnostics Market, Revenues & Volume, By End Use, 2021 - 2031 |
10 Africa Shrimp Disease Diagnostics Market, Overview & Analysis |
10.1 Africa Shrimp Disease Diagnostics Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Shrimp Disease Diagnostics Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Shrimp Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Shrimp Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Shrimp Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Shrimp Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Shrimp Disease Diagnostics Market, Revenues & Volume, By Type, 2021 - 2031 |
10.4 Africa Shrimp Disease Diagnostics Market, Revenues & Volume, By Testing Method, 2021 - 2031 |
10.5 Africa Shrimp Disease Diagnostics Market, Revenues & Volume, By Application, 2021 - 2031 |
10.6 Africa Shrimp Disease Diagnostics Market, Revenues & Volume, By End Use, 2021 - 2031 |
11 Europe Shrimp Disease Diagnostics Market, Overview & Analysis |
11.1 Europe Shrimp Disease Diagnostics Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Shrimp Disease Diagnostics Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Shrimp Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Shrimp Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Shrimp Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Shrimp Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Shrimp Disease Diagnostics Market, Revenues & Volume, By Type, 2021 - 2031 |
11.4 Europe Shrimp Disease Diagnostics Market, Revenues & Volume, By Testing Method, 2021 - 2031 |
11.5 Europe Shrimp Disease Diagnostics Market, Revenues & Volume, By Application, 2021 - 2031 |
11.6 Europe Shrimp Disease Diagnostics Market, Revenues & Volume, By End Use, 2021 - 2031 |
12 Middle East Shrimp Disease Diagnostics Market, Overview & Analysis |
12.1 Middle East Shrimp Disease Diagnostics Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Shrimp Disease Diagnostics Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Shrimp Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Shrimp Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Shrimp Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Shrimp Disease Diagnostics Market, Revenues & Volume, By Type, 2021 - 2031 |
12.4 Middle East Shrimp Disease Diagnostics Market, Revenues & Volume, By Testing Method, 2021 - 2031 |
12.5 Middle East Shrimp Disease Diagnostics Market, Revenues & Volume, By Application, 2021 - 2031 |
12.6 Middle East Shrimp Disease Diagnostics Market, Revenues & Volume, By End Use, 2021 - 2031 |
13 Global Shrimp Disease Diagnostics Market Key Performance Indicators |
14 Global Shrimp Disease Diagnostics Market - Export/Import By Countries Assessment |
15 Global Shrimp Disease Diagnostics Market - Opportunity Assessment |
15.1 Global Shrimp Disease Diagnostics Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Shrimp Disease Diagnostics Market Opportunity Assessment, By Type, 2021 & 2031F |
15.3 Global Shrimp Disease Diagnostics Market Opportunity Assessment, By Testing Method, 2021 & 2031F |
15.4 Global Shrimp Disease Diagnostics Market Opportunity Assessment, By Application, 2021 & 2031F |
15.5 Global Shrimp Disease Diagnostics Market Opportunity Assessment, By End Use, 2021 & 2031F |
16 Global Shrimp Disease Diagnostics Market - Competitive Landscape |
16.1 Global Shrimp Disease Diagnostics Market Revenue Share, By Companies, 2024 |
16.2 Global Shrimp Disease Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here